3,249 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 584 funds opening new positions, 1,250 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,250 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.25%67.22% (+0.97%)

Holders
3,249
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
3026
$230K
3027
$230K
3028
$229K
3029
$229K
3030
$229K
3031
$229K
3032
$229K
3033
$229K
3034
$228K
3035
$228K
3036
$228K
3037
$227K
3038
$227K
3039
$227K
3040
$227K
3041
$227K
3042
$226K
3043
$226K
3044
$225K
3045
$223K
3046
$222K
3047
$222K
3048
$222K
3049
$222K
3050
$221K